Ignite Connect 2026 | Kendra Batchelder - Medara: Predictive AI for Early Disease Detection скачать в хорошем качестве

Ignite Connect 2026 | Kendra Batchelder - Medara: Predictive AI for Early Disease Detection

Medara is transforming breast cancer screening with a multimodal predictive analytics platform that identifies women at high risk, even when mammograms appear normal. In this Ignite Connect 2026 pitch, founder Kendra Batchelder introduces an AI-based software solution that analyzes imaging, clinical data, and patient history to forecast near-term breast cancer development and drive earlier, more targeted interventions. Medara’s platform integrates seamlessly into existing radiology workflows and enhances both clinical decision-making and operational efficiency. Designed for breast imaging centers, the tool supports earlier detection, improves quality metrics, and unlocks new revenue potential via follow-up imaging (e.g., MRI) aligned with new FDA mandates and payer priorities. Medara is advancing toward FDA 510(k) clearance with support from academic and industry collaborators, including cancer centers and private payers. With a focus on breast cancer as a starting point, the company’s long-term vision includes expanding into AI-driven diagnostic navigation and clinical trial matching across other cancer types. This pitch is especially relevant for: Cornell researchers working in healthcare AI, diagnostics, and imaging technologies VCs and early-stage investors seeking breakthrough tools in digital health, women’s health, and precision oncology Imaging centers, radiology tech firms, and industry partners exploring licensing, OEM partnerships, or clinical pilots Learn more about the Center for Technology Licensing at Cornell: https://ctl.cornell.edu Visit the Ignite website to learn about the gap funding series: https://ctl.cornell.edu/ignite/ Explore the inaugural Ignite Impact Report: https://ctl.cornell.edu/wp-content/up... Watch more Ignite Connect 2026 pitch sessions in this playlist:    • Ignite Connect 2026: Accelerating Impact